[Recommendations for the diagnosis and treatment of glucocorticoid-induced osteoporosis].
Tanaka
Ikuko
I
Department of Biofunctional Research, National Institute for Longevity Sciences.
Oshima
Hisaji
H
D015519:Bone Density; D001862:Bone Resorption / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D004164:Diphosphonates / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors
D004164:Diphosphonates; D005938:Glucocorticoids; D011239:Prednisolone